PT94297B - Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem - Google Patents

Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem Download PDF

Info

Publication number
PT94297B
PT94297B PT94297A PT9429790A PT94297B PT 94297 B PT94297 B PT 94297B PT 94297 A PT94297 A PT 94297A PT 9429790 A PT9429790 A PT 9429790A PT 94297 B PT94297 B PT 94297B
Authority
PT
Portugal
Prior art keywords
formula
compound
amine
purin
lower alkyl
Prior art date
Application number
PT94297A
Other languages
English (en)
Portuguese (pt)
Other versions
PT94297A (pt
Inventor
Richard Charles Effland
Joseph Thomas Klein
Larry Davis
Gordon Edward Olsew
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of PT94297A publication Critical patent/PT94297A/pt
Publication of PT94297B publication Critical patent/PT94297B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Television Signal Processing For Recording (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PT94297A 1989-06-09 1990-06-07 Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem PT94297B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/363,837 US5017578A (en) 1989-06-09 1989-06-09 N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents

Publications (2)

Publication Number Publication Date
PT94297A PT94297A (pt) 1991-02-08
PT94297B true PT94297B (pt) 1997-01-31

Family

ID=23431950

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94297A PT94297B (pt) 1989-06-09 1990-06-07 Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem

Country Status (21)

Country Link
US (1) US5017578A (de)
EP (1) EP0402752B1 (de)
JP (1) JPH06102663B2 (de)
KR (2) KR100199524B1 (de)
CN (1) CN1029968C (de)
AT (1) ATE127807T1 (de)
AU (1) AU636351B2 (de)
CA (1) CA2018563C (de)
DE (1) DE69022294T2 (de)
DK (1) DK0402752T3 (de)
ES (1) ES2078267T3 (de)
FI (1) FI902850A0 (de)
GR (1) GR3017743T3 (de)
HU (1) HU207320B (de)
IE (1) IE68433B1 (de)
IL (1) IL94665A (de)
MX (1) MX21088A (de)
NO (1) NO902555L (de)
NZ (1) NZ233970A (de)
PT (1) PT94297B (de)
ZA (1) ZA904443B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 Ｎ−（置換アミノ）ピロール誘導体、その製造方法及び除草剤
BR9507683A (pt) * 1994-05-10 1997-09-23 Sandoz Ag Derivados de adenosina
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2004264419B2 (en) * 2003-08-15 2009-01-15 Irm Llc 6-substituted anilino purines as RTK inhibitors
CN100447143C (zh) * 2003-08-15 2008-12-31 Irm责任有限公司 作为rtk抑制剂的6-取代的苯胺基嘌呤
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104744470A (zh) * 2014-10-31 2015-07-01 合肥平光制药有限公司 一种茶碱的合成方法
US10653681B2 (en) 2016-03-16 2020-05-19 Recurium Ip Holdings, Llc Analgesic compounds
CN106632339B (zh) * 2016-12-16 2018-11-27 温州医科大学 一种6-取代-9h-嘌呤类衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016378A (en) * 1959-07-01 1962-01-09 Thomae Gmbh Dr K Amino-substituted purine derivatives
US3796700A (en) * 1970-06-30 1974-03-12 Takedo Chem Ind Ltd Adenosine derivatives and the production thereof
JPS4935635B1 (de) * 1970-12-28 1974-09-25
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US3936454A (en) * 1973-08-14 1976-02-03 Warner-Lambert Company 5-Amino-4-chloro-6-(substituted amino)-pyrimidines
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
ATE50777T1 (de) * 1984-04-18 1990-03-15 Whitby Research Inc Cardio-vasodilatatore n-6-substituierte adenosine.
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
CA1254888A (en) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicycloadenosines
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US4780452A (en) * 1986-09-08 1988-10-25 Burroughs Wellcome Co. F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
IE902077L (en) 1990-12-09
KR100210179B1 (ko) 1999-07-15
GR3017743T3 (en) 1996-01-31
DE69022294T2 (de) 1996-03-14
ES2078267T3 (es) 1995-12-16
KR100199524B1 (ko) 1999-06-15
EP0402752B1 (de) 1995-09-13
JPH0324080A (ja) 1991-02-01
HU207320B (en) 1993-03-29
US5017578A (en) 1991-05-21
CA2018563A1 (en) 1990-12-09
CN1029968C (zh) 1995-10-11
JPH06102663B2 (ja) 1994-12-14
NZ233970A (en) 1993-02-25
MX21088A (es) 1993-11-01
DK0402752T3 (da) 1996-01-15
IE68433B1 (en) 1996-06-12
KR910000730A (ko) 1991-01-30
EP0402752A1 (de) 1990-12-19
HU903768D0 (en) 1990-11-28
HUT54156A (en) 1991-01-28
CN1047866A (zh) 1990-12-19
FI902850A0 (fi) 1990-06-07
IL94665A0 (en) 1991-04-15
IL94665A (en) 1994-06-24
NO902555D0 (no) 1990-06-08
NO902555L (no) 1990-12-10
PT94297A (pt) 1991-02-08
AU636351B2 (en) 1993-04-29
DE69022294D1 (de) 1995-10-19
ZA904443B (en) 1991-03-27
CA2018563C (en) 2000-09-19
ATE127807T1 (de) 1995-09-15
AU5691990A (en) 1990-12-13

Similar Documents

Publication Publication Date Title
PT94297B (pt) Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem
KR100667645B1 (ko) 환상 아민 ｃｃｒ3 길항제
JP3514490B2 (ja) トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法
KR20070011483A (ko) Ｉｋｂ 키나제 억제제로서의 실질적으로 순수한2-｛[2-(2-메틸아미노-피리미딘-4-일)-1ｈ-인돌-5-카르보닐]-아미노｝-3-(페닐피리딘-2-일-아미노)-프로피온산
SK404291A3 (en) INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION COMPRISING THEMì (54) AND THEIR USE
KR20140059164A (ko) 트라이사이클릭 자이라제 억제제
TW201625618A (zh) 抑制瞬時受體電位ａ１離子通道
US20240092757A1 (en) HETEROARYL DIAMIDE IRE1/XBP1s ACTIVATORS
WO2023088418A1 (en) Compounds as sars-cov-2 inhibitors
EP0389984A1 (de) Carbonate des Eserolins, ein Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel
PT95579A (pt) Processo de preparacao de 1,2,3,4-tetra-hidro-isoquinolinas 6-substituidas e de composicoes farmaceuticas que as contem
CN104610233B (zh) 具有更高蛋白激酶g抑制活性的化合物及其制备方法
EP0425669B1 (de) 1-amino-5-halogenouracile, verfahren zu deren herstellung und diese enthaltende cns-depressiva
US20070142417A1 (en) Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor
WO2019001307A1 (zh) 一种酰胺类化合物及包含该化合物的组合物及其用途
US11814371B2 (en) Heterocyclic compound
WO2022125614A1 (en) Phosphonates as inhibitors of enpp1 and cdnp
JPS6230762A (ja) 新規５−オキソ−１−イミダゾリジンアセトアミド誘導体
ES2312968T3 (es) Compuestos novedosos.
US5155098A (en) N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
CN115536696B (zh) Enpp1抑制剂
CN102666563A (zh) 作为a2a受体激动剂的烷氧基羰基氨基炔基腺苷化合物及其衍生物
TW201302736A (zh) 組織蛋白酶（Ｃａｔｈｅｐｓｉｎ）Ｃ抑制劑
US6630477B1 (en) Therapeutic nucleoside compound
WO2022125613A1 (en) Phosphonates as inhibitors of enpp1 and cdnp

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961007

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040430